These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34816400)
1. Use of a Ferret Model to Test Efficacy and Immunogenicity of Live Attenuated Mycobacterium avium Subspecies paratuberculosis Vaccines. Bannantine JP; Gupta T; Zinniel DK; Hikal A; Quinn FD; Barletta RG Methods Mol Biol; 2022; 2411():95-104. PubMed ID: 34816400 [TBL] [Abstract][Full Text] [Related]
2. A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis. Bannantine JP; Hines ME; Bermudez LE; Talaat AM; Sreevatsan S; Stabel JR; Chang YF; Coussens PM; Barletta RG; Davis WC; Collins DM; Gröhn YT; Kapur V Front Cell Infect Microbiol; 2014; 4():126. PubMed ID: 25250245 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice. Bannantine JP; Everman JL; Rose SJ; Babrak L; Katani R; Barletta RG; Talaat AM; Gröhn YT; Chang YF; Kapur V; Bermudez LE Front Cell Infect Microbiol; 2014; 4():88. PubMed ID: 25072031 [TBL] [Abstract][Full Text] [Related]
4. Superior Protection from Live-Attenuated Vaccines Directed against Johne's Disease. Shippy DC; Lemke JJ; Berry A; Nelson K; Hines ME; Talaat AM Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27806993 [TBL] [Abstract][Full Text] [Related]
5. Attenuated strains of Mycobacterium avium subspecies paratuberculosis as vaccine candidates against Johne's disease. Settles EW; Kink JA; Talaat A Vaccine; 2014 Apr; 32(18):2062-9. PubMed ID: 24565753 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease. Park KT; Allen AJ; Bannantine JP; Seo KS; Hamilton MJ; Abdellrazeq GS; Rihan HM; Grimm A; Davis WC Vaccine; 2011 Jun; 29(29-30):4709-19. PubMed ID: 21565243 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of novel oral vaccine candidates and validation of a caprine model of Johne's disease. Hines ME; Turnquist SE; Ilha MR; Rajeev S; Jones AL; Whittington L; Bannantine JP; Barletta RG; Gröhn YT; Katani R; Talaat AM; Li L; Kapur V Front Cell Infect Microbiol; 2014; 4():26. PubMed ID: 24624365 [TBL] [Abstract][Full Text] [Related]
8. Superior protection elicited by live-attenuated vaccines in the murine model of paratuberculosis. Ghosh P; Shippy DC; Talaat AM Vaccine; 2015 Dec; 33(51):7262-7270. PubMed ID: 26546738 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium avium subsp. paratuberculosis antibody response, fecal shedding, and antibody cross-reactivity to Mycobacterium bovis in M. avium subsp. paratuberculosis-infected cattle herds vaccinated against Johne's disease. Tewari D; Hovingh E; Linscott R; Martel E; Lawrence J; Wolfgang D; Griswold D Clin Vaccine Immunol; 2014 May; 21(5):698-703. PubMed ID: 24623626 [TBL] [Abstract][Full Text] [Related]
10. Screening of Mycobacterium avium subsp. paratuberculosis mutants for attenuation in a bovine monocyte-derived macrophage model. Lamont EA; Talaat AM; Coussens PM; Bannantine JP; Grohn YT; Katani R; Li LL; Kapur V; Sreevatsan S Front Cell Infect Microbiol; 2014; 4():87. PubMed ID: 25072030 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of the Mycobacterium avium subsp. paratuberculosis attenuated mutants against challenge in a mouse model. Chen JW; Faisal SM; Chandra S; McDonough SP; Moreira MA; Scaria J; Chang CF; Bannantine JP; Akey B; Chang YF Vaccine; 2012 Apr; 30(19):3015-25. PubMed ID: 22107851 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Eshraghisamani R; Arrazuria R; Luo L; De Buck J Front Cell Infect Microbiol; 2023; 13():1149419. PubMed ID: 37065210 [TBL] [Abstract][Full Text] [Related]
13. A bovine macrophage screening system for identifying attenuated transposon mutants of Mycobacterium avium subsp. paratuberculosis with vaccine potential. Scandurra GM; Young M; de Lisle GW; Collins DM J Microbiol Methods; 2009 Apr; 77(1):58-62. PubMed ID: 19386227 [TBL] [Abstract][Full Text] [Related]
14. Vaccine approaches for the 'therapeutic management' of Gupta S; Singh SV; Singh M; Chaubey KK; Karthik K; Bhatia AK; Kumar N; Dhama K Vet Q; 2019 Dec; 39(1):143-152. PubMed ID: 31524561 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and efficacy of an oral live-attenuated vaccine for bovine Johne's disease. Eshraghisamani R; Facciuolo A; Harman-McKenna V; Illanes O; De Buck J Front Immunol; 2023; 14():1307621. PubMed ID: 38283338 [No Abstract] [Full Text] [Related]
16. 'Bio-load' and bio-type profiles of Mycobacterium avium subspecies paratuberculosis infection in the domestic livestock population endemic for Johne's disease: a survey of 28 years (1985-2013) in India. Singh SV; Singh PK; Singh AV; Sohal JS; Kumar N; Chaubey KK; Gupta S; Rawat KD; Kumar A; Bhatia AK; Srivastav AK; Dhama K Transbound Emerg Dis; 2014 Aug; 61 Suppl 1():43-55. PubMed ID: 25135463 [TBL] [Abstract][Full Text] [Related]